BE640616A - - Google Patents

Info

Publication number
BE640616A
BE640616A BE640616DA BE640616A BE 640616 A BE640616 A BE 640616A BE 640616D A BE640616D A BE 640616DA BE 640616 A BE640616 A BE 640616A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of BE640616A publication Critical patent/BE640616A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/005—Coating of tablets or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE640616D 1962-12-19 BE640616A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US245681A US3119742A (en) 1962-12-19 1962-12-19 Method of preparing sustained release pharmaceutical pellets and product thereof

Publications (1)

Publication Number Publication Date
BE640616A true BE640616A (fr)

Family

ID=22927638

Family Applications (1)

Application Number Title Priority Date Filing Date
BE640616D BE640616A (fr) 1962-12-19

Country Status (5)

Country Link
US (1) US3119742A (fr)
BE (1) BE640616A (fr)
GB (1) GB1030127A (fr)
IT (1) IT983055B (fr)
SE (1) SE328670B (fr)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH637297A5 (fr) * 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
US4507276A (en) * 1982-08-20 1985-03-26 Bristol-Myers Company Analgesic capsule
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
US4755387A (en) * 1985-03-21 1988-07-05 The Procter & Gamble Company Therapeutic particles
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
CA1279574C (fr) * 1985-04-17 1991-01-29 Jeffrey L. Finnan Procede de lubrification de poudres de vitamines hydrosolubles
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
US4904476A (en) * 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
US5019302A (en) * 1986-03-12 1991-05-28 Washington University Technology Associates, Inc. Method for granulation
SE8701479L (sv) * 1987-04-09 1988-10-10 Carbomatrix Ab Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
FI77573C (fi) * 1987-05-08 1989-04-10 Orion Yhtymae Oy Ny konsistens.
JP2668880B2 (ja) * 1987-06-23 1997-10-27 日本油脂株式会社 被覆アミノ酸類の製造方法
DE3721721C1 (de) * 1987-07-01 1988-06-09 Hoechst Ag Verfahren zur Umhuellung von Granulaten
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
ES2208433T3 (es) 1999-12-10 2004-06-16 Pfizer Products Inc. Compuestos de pirrolo(2,3-d)pirimidina como inhibidores de proteina quinasas.
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
CA2404626A1 (fr) * 2000-03-31 2001-10-04 Pfizer Products Inc. Nouveaux derives de piperazine
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
WO2002032901A2 (fr) * 2000-10-19 2002-04-25 Pfizer Products Inc. Derives de piperazine pontes
HUP0400369A2 (hu) * 2001-06-20 2004-12-28 Pfizer Products Inc. Új szulfonsavszármazékok és ezeket tartalmazó gyógyszerkészítmények
KR20040047941A (ko) * 2001-10-22 2004-06-05 화이자 프로덕츠 인크. Ｃｃｒ1 수용체 길항제 활성을 갖는 피페라진 유도체
CA2484860A1 (fr) * 2002-05-14 2003-11-20 Pfizer Products Inc. Derives d'acide dihydroxyhexanoique, leurs intermediaires et procedes de preparation correspondants
CA2484342A1 (fr) * 2002-05-14 2003-11-20 Pfizer Products Inc. Procedes de preparation de derives de dihydro-furan-2-one
PA8575901A1 (es) * 2002-07-18 2004-07-20 Pfizer Prod Inc Derivados de piperidina novedosos
OA12894A (en) * 2002-08-12 2006-10-13 Pfizer Prod Inc Crystal forms of quinoxaline-2-carboxylic acid [4-carbamoy 1-1-(3-fluorobenzyl)-2,7-dihydroxy-7-met hyl-octyl]-amide.
EP2165708A3 (fr) 2002-09-18 2010-07-28 Pfizer Products Inc. Nouveaux composés de pyrazole utilisés comme inhibiteurs du facteur de croissance transformant (TGF)
US20040097554A1 (en) * 2002-10-30 2004-05-20 Pfizer Inc Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
US20040087571A1 (en) * 2002-10-30 2004-05-06 Pfizer Inc Methods of using CCR1 antagonists as immunomodulatory agents
US20040116441A1 (en) * 2002-10-30 2004-06-17 Pfizer Inc Methods of using sulfonic acid derivatives
KR100678800B1 (ko) * 2002-11-21 2007-02-05 화이자 프로덕츠 인코포레이티드 3-아미노-피페리딘 유도체 및 그의 제조 방법
AU2003276591A1 (en) * 2002-11-26 2004-06-18 Pfizer Products Inc. Method of treatment of transplant rejection
BR0317244A (pt) * 2002-12-13 2005-11-01 Pfizer Prod Inc Derivados de piperazina contendo fósforo como antagonistas ccr1
PA8591801A1 (es) 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
ES2264795T3 (es) * 2003-02-14 2007-01-16 Pfizer Products Inc. Triazolo-piridinas como compuestos antiinflamatorios.
PA8595001A1 (es) * 2003-03-04 2004-09-28 Pfizer Prod Inc Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf)
ES2308151T3 (es) * 2003-03-11 2008-12-01 Pfizer Products Inc. Compuestos de pirazina como inhibidores del factor de crecimiento transformante (tgf).
US20050119275A1 (en) * 2003-06-24 2005-06-02 Pfizer Inc. Salt and crystal forms of (5-chloro-2-{2-[4-(4-fluoro-benzyl)-(2R,5S)-2,5-dimethyl-piperazin-1-yl]-2-oxo-ethoxy}-phenyl)-methanesulfonic acid
JP2007512316A (ja) * 2003-11-25 2007-05-17 ファイザー・プロダクツ・インク アテローム性動脈硬化症の治療方法
TW201038578A (en) 2009-01-30 2010-11-01 Univ Rutgers Methods to treat cancer
US8461102B2 (en) * 2010-03-02 2013-06-11 George E. Royster, JR. Methods and compositions for treating and preventing symptoms of hormonal variations
MX368340B (es) 2011-03-18 2019-09-30 Genzyme Corp Inhibidores de glucosilceramida sintasa.
JP2014513727A (ja) 2011-05-16 2014-06-05 ジェンザイム・コーポレーション Ｃｘｃｒ４拮抗薬の使用
CA2844577A1 (fr) 2011-09-13 2013-03-21 Ottawa Hospital Research Institute Inhibiteurs de micro-arn microrna inhibitors
MA37975B2 (fr) 2012-09-11 2021-03-31 Genzyme Corp Inhibiteurs de synthase de glucosylcéramide
SG11201507346PA (en) 2013-03-13 2015-10-29 Boston Biomedical Inc 3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer
EP3060234A1 (fr) 2013-10-24 2016-08-31 AbbVie Inc. Inhibiteur sélectif de jak1 et ses utilisations
US10065937B2 (en) 2014-07-31 2018-09-04 Inserm (Institut National De La Sante Et De La Recherche Medicale) FLT3 receptor antagonists
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
US20180237424A1 (en) 2015-03-03 2018-08-23 Inserm (Institut National De La Sante Et De La Recherche Medicale) Fgfr3 antagonists
TW201642855A (zh) 2015-03-10 2016-12-16 健臻公司 用於治療蛋白質病變之方法
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
AU2017294572B2 (en) 2016-07-08 2021-11-04 Chu De Nice 4-anilino-quinoline compounds as anti-cancer agents
ES2968559T3 (es) 2018-01-05 2024-05-10 Inst Nat Sante Rech Med Derivados de haloquinolina sustituidos, método de preparación y aplicaciones de los mismos
WO2020072796A1 (fr) 2018-10-03 2020-04-09 Tesaro, Inc. Formes cristallines d'une base libre de niraparib
EP3860981B1 (fr) 2018-10-03 2023-11-29 Tesaro, Inc. Sels du niraparib
KR20210123352A (ko) 2019-02-04 2021-10-13 젠자임 코포레이션 리소좀 축적 질환과 연관된 증상 및 장애를 치료하기 위한 방법
JP2022519131A (ja) 2019-02-04 2022-03-18 ジェンザイム・コーポレーション グルコシルセラミドシンターゼ（ｇｃｓ）阻害剤を使用した繊毛病の処置
KR20220136887A (ko) 2020-02-03 2022-10-11 젠자임 코포레이션 리소좀 축적 질환과 연관된 신경계 증상을 치료하기 위한 방법
CN116133647A (zh) 2020-07-24 2023-05-16 建新公司 包含文鲁司他的药物组合物
CN116322663A (zh) 2020-09-30 2023-06-23 比奥维拉迪维治疗股份有限公司 Ampk激活剂及其使用方法
TW202241888A (zh) 2020-12-23 2022-11-01 美商健臻公司 氘化群落刺激因子-1受體(csf-1r)抑制劑
WO2023196640A1 (fr) 2022-04-08 2023-10-12 Bioverativ Therapeutics Inc. Dérivés d'oxindole en tant qu'activateurs d'ampk destinés à être utilisés dans le traitement de troubles du sang rare
WO2024116127A1 (fr) 2022-12-01 2024-06-06 Genzyme Corporation Venglustat en combinaison avec un inhibiteur fort ou modéré de cyp3a4

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2738303A (en) * 1952-07-18 1956-03-13 Smith Kline French Lab Sympathomimetic preparation
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments

Also Published As

Publication number Publication date
GB1030127A (en) 1966-05-18
SE328670B (fr) 1970-09-21
US3119742A (en) 1964-01-28
DE1492128A1 (de) 1969-08-07
IT983055B (it) 1974-10-31

Similar Documents

Publication Publication Date Title
BE616548R (fr)
BE630590A (fr)
BE615521A (fr)
AU480751A (fr)
BE614380A (fr)
BE489310A (fr)
BE629302A (fr)
BE538252A (fr)
BE538831A (fr)
BE541929A (fr)
BE553896A (fr)
BE559145A (fr)
BE586180A (fr)
BE592434A (fr)
BE599783A (fr)
BE614403A (fr)
BE604335A (fr)
BE608197A (fr)
BE609543A (fr)
BE612190A (fr)
BE612311A (fr)
BE612464A (fr)
BE612847A (fr)
BE612926A (fr)
BE640616A (fr)